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Abstract
In recent years the prevalence of implantation of a cardiac implantable electronic device (CIED) has increased due to
expanding implantation indications and prolonged life expectancy. Diagnostic strategies increasingly employ magnetic
resonance imaging (MRI) to aid therapeutic strategies. In earlier guidelines, MRI was contra-indicated in patients with
CIEDs, mainly due to previous reports of severe complications. With the development of MRI-conditional CIEDs and recent
evidence concerning non-MRI-conditional CIEDs, MRIs in CIED patients can be safely performed in many hospitals.
However, there are several questions that need to be addressed. Which patients can we scan? How can the scans be
performed safely? And last but not least, can cardiac MRI provide diagnostic yield in patients with CIEDs?
Current European guidelines are rather outdated and vague about patient selection and practical issues. There are national
guidelines on this topic but several issues need extra attention and those are addressed in this point of view. It is important
to create an environment with proper patient selection without unnecessary MRI scans in CIED patients, but also without
unnecessary fear of complications, preventing access to MRI in patients who can benefit from this powerful diagnostic
tool.
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Introduction
In recent years the prevalence of implantation of a cardiac
implantable electronic device (CIED) has increased [1]
due to expanding implantation indications and prolonged
life expectancy. This increase has been observed with
both pacemakers and implantable cardioverter defibrilla-
tors (ICDs), as well as with implantable loop recorders. As
pacemaker and ICD patients are prone to develop signifi-
cant comorbidities, it is crucial that protocols for medical
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diagnostic and therapeutic procedures are established and
followed to avoid temporary or permanent device malfunc-
tioning (reviewed in [2]).
Diagnostic strategies increasingly employ magnetic res-
onance imaging (MRI). Over the last decades the number
of MRI scans has doubled every 5 years [3]. It is estimated
that 28% of CIED patients will have an indication for MRI
scanning in a period of 4 years with one third of patients
needing more than one scan [3]. In earlier guidelines, MRI
was contra-indicated in patients with a CIED, mainly due
to previous reports of severe complications. Major safety
concerns were induction of arrhythmias, tip heating, me-
chanical concerns and electromagnetic effects[2].
With the development of MRI-conditional pacemakers in
2008, MRI-conditional ICDs in 2011, and recent evidence
concerning non-MRI-conditional CIEDs, performing MRI
scans in CIED patients has become part of daily routine in
many hospitals. Whereas first-generation MRI-conditional
devices had specially developed leads with a higher chance
of peri-operative complications [4], presently most current
leads and devices have an MRI-conditional label. In the
latest European pacing guidelines, performing MRI in pa-
tients with MRI-conditional devices has received a Class
IIa indication whereas non-MRI-conditional devices have
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received a Class IIb indication for MRI scanning [5]. Since
the publication of these, rather outdated, guidelines several
new publications increased the body of evidence concern-
ing safety of MRI in patients with non-MRI-conditional
devices. A fairly recent expert consensus statement of the
Heart Rhythm Society provides extensive recommendations
on several issues [6]. The Netherlands Society of Cardi-
ology has also published practice guidelines surrounding
MRI and CIEDs (https://www.nvvc.nl/media/richtlijn/237/
Leidraad%20MRI.pdf).
A recent study confirms that the accumulating evidence
of safe MRI in CIED patients has not yet translated into
wide-spread access to MRI. Still, in patients with pace-
makers, and even more so in patients with ICDs, MRI is
denied by cardiologists or radiologists [7].
This point of view focuses on several practical issues:
patient selection, considerations for programming and pa-
tient safety. Patients who might benefit from MRI should
preferably not be denied access to this powerful diagnostic
tool. We also discuss the possibility of performing cardiac
MRI in patients with CIEDs as this is thought to be diffi-
cult, if not impossible, due to artefacts created by the metal-
containing parts of the CIED system.
Patient selection
Modern CIEDs from most manufacturers are labelled MRI-
conditional. This concerns both pacemakers and ICDs, and
includes modern techniques such as leadless pacemakers
[8] and the subcutaneous ICD [9]. Several electrodes that
have been on the market for quite some time also received
the MRI-conditional label and when they are connected to
a modern pacemaker or ICD from the same manufacturer,
the whole system is MRI-conditional. Frequently, during
device replacement or de novo implantations MRI-condi-
tional components of several manufacturers are mixed and
in that case the whole system cannot be labelled MRI-con-
ditional.
MRI-conditional labelling is usually acquired by techni-
cal construction calculations and in vitro testing. Clinical
patient data before achievement of the label were scarce
but are accumulating after introduction into the market.
For FDA licensing purposes, 2,629 CIED patients were
prospectively followed and underwent a total of 872 MRI
scans without any complications [3]. Clinical data are avail-
able in non-MRI-conditional systems as well. Currently,
these data are robust with a very large prospective reg-
istry including 1,500 patients who underwent non-thoracic
MRI in the MagnaSafe registry [10] and a recent meta-
analysis which included 5,099 patients [11]. As yet, less
data are available on the safety of MRI in patients with
abandoned leads or epicardial leads. Even though several
studies showed no serious adverse events in patients with
abandoned leads [12, 13], sensitive markers of lead or tis-
sue damage, such as changes in impedance or threshold,
cannot be assessed. Other investigators found no problems
with several issues posing a contraindication for MRI, such
as batteries close to depletion and recall components [14].
Epicardial electrodes might pose a greater risk for use in
the MRI environment since they have the disadvantage of
not being cooled by blood flow. They were typically used in
children and patients with congenital heart disease, but are
nowadays increasingly used in patients who need cardiac
resynchronisation therapy as well [15]. The lifetime chance
of the need for MRI in young patients especially is very
high and we urgently need data demonstrating the safety of
MRI in patients with epicardial electrodes. The same holds
true for patients with older, non-MRI-conditional coronary
sinus electrodes.
Practical issues around theMRI scan
To assure that a patient can be scanned safely, several steps
have to be taken. These practical considerations evolve
around the CIED system, but also involve MRI settings and
patient monitoring during the scan (summarized in Fig. 1).
MRI scans in CIED patients require specific attention
from the referring clinical department as well as the radi-
ology and the cardiology departments. Therefore, as a first
step, these labour-intensive scans should be reserved for pa-
tients that actually derive benefit, i. e. the scan should have
clear therapeutic or prognostic implications that cannot be
obtained by other diagnostic means. Before scheduling the
patient this needs to be taken into account. Secondly, it
needs to be determined whether the patient has an MRI-con-
ditional or non-MIR-conditional system. According to man-
ufacturer specifications of the MRI-conditional system, an
MRI technical specialist should document the specific MRI
conditions (e.g. Tesla, specific absorption rates, etcetera)
(see Table 1). Thirdly, information has to be available about
pacemaker dependency and recent technical measurements.
Measurements should be within normal range and devices
should not be near the end of their battery life given the
chance of switching to a safe replacement mode during the
scan.
At the day of the scan, actual technical measurements
should be performed and the device has to be reprogrammed
according to manufacturer’s specifications in MRI-condi-
tional devices. This specific programming is part of the
conditions under which MRI is possible. In pacemaker-
dependent patients an asynchronous mode should be pro-
grammed (VOO or DOO). In non-pacemaker-dependent pa-
tients a VVI of DDI mode should be programmed, however,
in patients with high pacing percentages asynchronous pac-
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Fig. 1 Flow diagram of pa-
tient selection and device pro-
gramming for magnetic reso-
nance imaging. MRI magnetic
resonance imaging, HR heart
rate, PM pacemaker, ICD im-
plantable cardioverter defib-
rillator, CS coronary sinus,
ECG electrocardiogram
Table 1 Technical considerations for MRI in patients with cardiac
implantable electronic devices
Technical specification of magnetic resonance imaging
For MRI-conditional devices follow manufacturer’s instructions for
scan
For non-MRI-conditional devices:
– 1.5T MRI should be preferred
– Gradient slew rate should not exceed 200T/m/s
– Dorsal patient position
– Imaging landmark near the device (thorax) should be avoided
– Local transmit coils should be avoided
– SAR and scan time should be limited
Emergency equipment/external defibrillator as well as a device pro-
grammer should be present during the MRI
Continuous patient monitoring (electrocardiography/pulse oximetry)
during the MRI should be performed
MRI magnetic resonance imaging, SAR specific absorption rate
ing modes might be preferable. Additional advanced pacing
features should be deactivated. In ICD patients all ICD ther-
apies should be deactivated (see Table 2).
During the scan the patient should be monitored using
electrocardiography (ECG) and/or plethysmography. The
latter may be the preferable technique because ECG moni-
toring might be disturbed during the scan, whereas plethys-
mographic signals usually are not. However, plethysmogra-
phy obviously remains sensitive to loss of contact if the pa-
tient is moving his fingers. Therefore, monitoring should be
performed by a professional trained in haemodynamic mon-
itoring who is also aware of the possible scenarios needing
intervention (Table 3). ‘Power-on resets’ occur relatively
frequently, especially in non-MRI-conditional devices lead-
ing to a change of pacing mode that is susceptible to over-
sensing [12]. An external defibrillator with external pacing
capability should always be present in close proximity of
the MRI scanner and the available personnel needs to be
trained in its use. Currently, there is increasing evidence that
magnet resonance scanning can also be performed without
monitoring, especially in acute settings when monitoring is
not readily available, due to the low rate of problems during
the scan [16].
After the scan, the programme settings of the device
should be restored to the pre-MRI settings and techni-
cal measurements should be performed. Special attention
should be paid to changes in electrode impedances, sens-
ing, pacing thresholds and battery measurements. In case
of significant changes a prolonged period of observation
should be considered.
Cardiac MRI in patients with CIEDs
Non-invasive cardiac imaging is important for diagnostics
[17] and planning of therapeutic interventions [18].
Previously, cardiac MRI was thought to be difficult, if not
impossible, in patients with CIEDs due to artefacts created
by the metal-containing parts of the CIED system.
Houten 2018
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Table 2 Advice for programming devices in non-MRI-conditional
patients undergoing magnetic resonance scanning
In pacemaker-dependent patients: asynchronous mode (VOO/DOO)
with HF of 80–90/min with high output, RV-only pacing in biventric-
ular devices
In non-pacemaker-dependent patients:
– Resting heart rate >50/min: VVI or DDI 30–40/min
– Resting heart rate <50/min: consider VOO/DOO 80–90/min with
high output
– RV-only pacing in CRT patients
Deactivate additional features:
– Rate response mode
– Anti-tachycardia therapies (including anti-tachycardia pacing and
shocks)—ICD only
– LV-triggered pacing (ventricular sense response)—biventricular
devices only
– Anti-pacemaker-mediated tachycardia pacing (PMT algorithms)
– PVC-triggered pacing response
– PAC-triggered pacing response
– Atrial fibrillation therapies (rate smoothing, overdrive pacing, con-
ducted atrial fibrillation response)
– Hysteresis pacing
– Magnet response (if the option exists)
– Noise response
MRI magnetic resonance imaging, HF heart frequency, RV right
ventricular, CRT cardiac resynchronisation therapy, ICD implantable
cardioverter defibrillator, LV left ventricular, PMT pacemaker-
mediated tachycardia, PVC premature ventricular contraction,
PAC premature atrial contraction
Table 3 Scenarios during magnetic resonance imaging requiring
immediate action of the observing professional
Scenario Possible reasons
Asystole Device malfunction in asynchronous mode
‘Power-on reset’ with pacing inhibition by noise
True bradycardia in non-pacemaker dependent
patients in inhibitory mode
Ventricular
fibrillation/
tachycardia
R-on-T phenomenon in asynchronous pacing
mode
True arrhythmia
Sudden rise in
heart rate
‘Power-on reset’ in inhibitory mode leading to
pacing
True endogenous tachycardia
Sudden drop in
heart rate
‘Power-on reset’ in asynchronous mode
True endogenous bradycardia in inhibitory mode
Recent developments have shown that with specific MRI
settings cardiac MRIs can be performed with reasonable
quality. This is especially true in pacemaker implants in
the right pectoral region and to a lesser degree in left-
sided pacemakers and even less in ICDs due to the larger
metal-containing battery. In non-MRI-conditional systems,
thoracic MRIs have only partly been included in the large
prospective registries but seem to be safe [19]. In this study,
wideband pulse sequence for late gadolinium enhancement
yields a high rate of studies unaffected by artefacts.
Conclusions
MRI can be safely performed in both patients with MRI-
conditional and non-MRI-conditional systems if specific
programming is performed, technical limitations of mag-
netic resonance scanning are taken into consideration and
patients are adequate monitored. Even cardiac MRI can be
performed if the correct protocols are followed. Cardiolo-
gists and radiologists should be familiar with the protocols
and not deny patients access to this powerful diagnostic
tool.
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